يحاول ذهب - حر
Zydus announces results from EPICS-III phase 2(b)/3 trial
September 18, 2025
|Chronicle Pharmabiz
ZYDUS Therapeutics, a wholly owned subsidiary of Zydus Lifesciences Ltd., a global innovation led healthcare company, announced positive topline results from the pivotal EPICS-III phase 2(b)/3 clinical trial.
-
In this trial, the safety and efficacy of saroglitazar, an investigational alpha/ gamma peroxisome proliferator-activated receptor (PPAR) agonist, was evaluated for the treatment of adult patients with primary biliary cholangitis (PBC) who had an inadequate response or intolerance to ursodeoxycholic acid (UDCA), the current standard-of-care.
هذه القصة من طبعة September 18, 2025 من Chronicle Pharmabiz.
اشترك في Magzter GOLD للوصول إلى آلاف القصص المتميزة المنسقة، وأكثر من 9000 مجلة وصحيفة.
هل أنت مشترك بالفعل؟ تسجيل الدخول
المزيد من القصص من Chronicle Pharmabiz
Chronicle Pharmabiz
FOPE urges Petroleum Min to prioritise LPG supply to pharma sector
THE Federation of Pharma Entrepreneurs (FOPE) is now concerned about the shortage of LPG (Liquefied Petroleum Gas) following the looming uncertainty with the ongoing war in West Asia.
1 mins
March 19, 2026
Chronicle Pharmabiz
BDCDA informs FDA about challenges to implement geo-tagging
THE Bangalore District Chemists and Druggists Association (BDCDA) has apprised the Karnataka FDA about the practical challenges in implementing the FDA's geo-tagging application.
1 mins
March 19, 2026
Chronicle Pharmabiz
₹1,000 cr MedTech Fund signals shift toward domestic mfg
THE Indian medical technology sector is poised for a major transformation with the launch of MedArtha Capital, the nation’s first dedicated Rs.1,000 crore growth fund focused exclusively on medtech.
1 mins
March 19, 2026
Chronicle Pharmabiz
Pharma exports to GCC countries affected by US-Israel-Iran conflict: Experts
PHARMA exports to the Gulf Cooperation Council (GCC) countries like UAE, Saudi Arabia and West Asia-North Africa (WANA) region have been badly affected due to the USIsrael-Iran conflict.
2 mins
March 19, 2026
Chronicle Pharmabiz
SEPC, AHPI hold program for wellness centres & MVTF
THE Services Export Promotion Council (SEPC) India and the Association of Healthcare Providers (AHPI) India successfully held its first meeting recently on creating an accreditation programme for Wellness Centers and Medical Value Travel Facilitators (MVTF).
1 mins
March 19, 2026
Chronicle Pharmabiz
DGFT launches risk sharing support to boost exports
IN a strategic move to expand India's global export footprint, the DGFT has introduced a new intervention under the Export Promotion Mission (EPM) aimed at strengthening export financing and improving trade access to under-served markets.
1 min
March 19, 2026
Chronicle Pharmabiz
'Need to transition from awareness reporting to performance-oriented PV'
THERE is a need to transition from awareness-driven reporting to a performance-oriented pharmacovigilance (PV) framework with measurable outcomes, said Dr V Kalaiselvan, secretary-cum-scientific director, the Indian Pharmacopoeia Commission (IPC) at the 1st Annual Meeting of Regional Centres participating in the Pharmacovigilance Programme of India (PvPI) and the Materiovigilance Programme of India (MvPI).
1 mins
March 19, 2026
Chronicle Pharmabiz
India's drug quality surveillance hits new highs
THE Central Drugs Standard Control Organisation (CDSCO) has released a comprehensive report detailing the quality surveillance of pharmaceuticals across India over the last five fiscal years.
2 mins
March 19, 2026
Chronicle Pharmabiz
Pharma Quality Excellence Awards 2026 in Mumbai
In an era of heightened regulatory scrutiny, global supply chain complexity, and accelerated innovation, compliance alone is no longer sufficient.
1 min
March 19, 2026
Chronicle Pharmabiz
Healthcare workforce eyes AI dominance via digital upskilling
INDIA'S healthcare workforce, armed with digital upskilling, is poised for AI dominance, but there are certain creases in the system that need to be ironed out for more efficient integration.
1 min
March 19, 2026
Listen
Translate
Change font size